Transdermal Drug Delivery Systems (TDDS): Recent Advances and Failure Modes

Area of Science:

• Pharmacology
• Biomedical Engineering
• Materials Science

Background:

• Transdermal drug delivery systems (TDDS), or patches, provide a nonintrusive method for medication administration.
• TDDS release specific dosages at controlled rates directly into the bloodstream, bypassing oral metabolism.
• Existing TDDS are used for various medications, with ongoing research into biologic delivery.

Purpose of the Study:

• To review the current literature on the efficacy of medical TDDS for transdermal drug delivery.
• To identify potential risks and failure modes in TDDS design and development.
• To outline strategies for mitigating identified risks to ensure therapeutic quality.

Main Methods:

• Comprehensive literature review of transdermal drug delivery systems.
• Analysis of TDDS efficacy, including drug release kinetics and bioavailability.
• Examination of reported failure modes and associated risk factors in TDDS.

Main Results:

• TDDS demonstrate significant advantages in convenience and reduced invasiveness compared to traditional methods.
• The review identifies key failure modes, including adhesion issues, drug leakage, and insufficient release rates.
• Strategies for risk mitigation focus on material selection, formulation optimization, and manufacturing process control.

Conclusions:

• TDDS represent a promising platform for effective drug delivery, including biologics.
• Understanding and addressing failure modes is crucial for developing safe and efficacious transdermal therapeutics.
• Proactive risk management in TDDS design and development is essential for clinical success.